One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique

September 21, 2016 updated by: Shaimaa Mohamed Mostafa Rohym, Cairo University

Double Blinded Randomized Clinical Trial for Evaluation of Resin Modified Glass Ionomer Cement Versus Resin Infiltration in Treating White Spot Lesions

The aim of this study is to evaluate the addition of new technology of resin modified glass-ionomer in comparison to resin infiltration in treating post-orthodontic white spot lesions; both applies into the same patient's mouth; to reveal which material will have more clinical satisfactory performance inside the oral cavity and to overcome the high expensive cost in treating such clinical cases

Study Overview

Detailed Description

Roles and responsibilities:

  • Shaimaa Mohammed (SH.M.): Operator and author.Specialist in Air-Force Specialized Hospital.
  • Mohamed Riad (M.R.): Main supervisor, data monitoring and auditing, Professor, Conservative Dentistry Department,Cairo University.
  • Asma Harhash(A.H.):Co-supervisor, outcome assessor and data collection, Associate Professor, Russian University.
  • Omnia Magdy Moustafa (O.M.): Baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents: Assistant lecturer, Conservative Dentistry Department , Faculty of Oral and Dental Medicine Cairo University.
  • Ghada Ahmed (G.A.): Data entry and auditing; Assistant lecturer, Conservative Dentistry Department, Faculty of Oral and Dental Medicine, Russian University.

Intervention:

A- Preoperative clinical assessment:

  1. Explain patient need toward aesthetic needs
  2. Digital photos for white spot lesions
  3. Recording number of white spot lesions and site. (SH.M.) will apply both materials at the same patient mouth (Split mouth technique) according to the manufacturer's instructions.

    • Intervention: resin modified glass ionomer cement varnish: Vanish™ xt Extended Contact Varnish (3M ESPE Dental)
    • Comparator: resin infiltration (Dental Milestones Guaranteed, Germany).

(A.H) and (SH.M) will assess the outcome measures through the follow up time: immediately after,1 day, 1 week,1 month,3 months, 6 months, 12 months

Study Type

Interventional

Enrollment (Anticipated)

35

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 35 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Post-Orthodontic patients included in this clinical trial toll age of 35 years.
  2. Patients with good general health.
  3. Patients who will agree to the consent and will commit to follow-up period.
  4. Fully erupted anterior teeth with no cavitated lesions.
  5. At least one spot lesion on each side in the same jaw

Exclusion Criteria:

  1. Patients with any systemic disease that may affect normal healing.
  2. Patient with bad oral hygiene.
  3. Tetracycline or fluorsis staining.
  4. Patients who could/would not participate in all times of follow-up.
  5. Untreated periodontal disease was not allowed.
  6. Active caries or defective Restorations in 6 anterior teeth.
  7. Bleaching history
  8. Patients participating in more than 1 dental study.
  9. Patient received fluoride varnish during orthodontic treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vanish xt Extended Contact Varnish
Vanish xt Extended Contact Varnish is a resin modified glass ionomer cement and fluoride varnish used to treat white spot lesions to be more resistant to early caries progression.
resin modified glass- ionomer cement varnish applied as a thin layer coating and cured
Other Names:
  • Clinpro xt
Active Comparator: Resin infiltration
Resin infiltration is a low viscous resin infiltrates into small pores of white spot lesions to block entrance of bacteria into dentinal tubules of the tooth and more resistant to early caries progression.
low viscous light cure resin applied in layers and cured
Other Names:
  • ICON

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Patient satisfaction
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
using visual analogue scale ruler (0-100 mm) 0 refer to not satisfied at all,100 refer to total satisfied
immediately, 1 day, 1week,1 month,3 month,6 month and1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in color change
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
using vita easy shade device
immediately, 1 day, 1week,1 month,3 month,6 month and1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in caries lesion state
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
Diagnodent device
immediately, 1 day, 1week,1 month,3 month,6 month and1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ahmed Elkhadem, PhD, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Anticipated)

January 1, 2018

Study Completion (Anticipated)

May 1, 2018

Study Registration Dates

First Submitted

September 20, 2016

First Submitted That Met QC Criteria

September 21, 2016

First Posted (Estimate)

September 23, 2016

Study Record Updates

Last Update Posted (Estimate)

September 23, 2016

Last Update Submitted That Met QC Criteria

September 21, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • CEBD-CU-2016-09-209

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe